Intraperitoneal chemotherapy: Belly-bath or pain-in-the-side?

Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer.

1978 • 707 citations

The pharmacokinetics of Norpace.

1975 • 567 citations

Intraperitoneal Cisplatin with Systemic Thiosulfate Protection

1982 • 494 citations

Prospective, randomized trial of intravenous versus intraperitoneal 5-fluorouracil in patients with advanced primary colon or rectal cancer.

1985 • 243 citations

Phase I and pharmacological studies of adriamycin administered intraperitoneally to patients with ovarian cancer.

1982 • 218 citations

Portal levels and hepatic clearance of 5-fluorouracil after intraperitoneal administration in humans.

1981 • 211 citations

Experimental and clinical results with intraperitoneal cisplatin.

1985 • 150 citations

Ip cisplatin in patients with malignant ascites: pharmacokinetic evaluation and comparison with the iv route.

1983 • 133 citations

High-volume intraperitoneal chemotherapy with methotrexate in patients with cancer.

1981 • 100 citations

Intraperitoneal chemotherapy: technical experience at five institutions.

1985 • 92 citations

Long-duration intracavitary infusion of methotrexate with systemic leucovorin protection in patients with malignant effusions.

1981 • 76 citations

Prospective randomized trial of intravenous v intraperitoneal 5-FU in patients with advanced primary colon or rectal cancer.

1985 • 67 citations

Pharmacokinetics of Ip cisplatin in refractory ovarian carcinoma.

1983 • 66 citations

VP-16 in the treatment of malignant lymphomas: a report from the Swiss Group for Clinical Cancer Research (SAKK).

1985 • 27 citations

Intraperitoneal chemotherapy: the use of concurrent systemic neutralizing agents.

1985 • 19 citations

Pharmacokinetics and efficacy of i.v. and i.p. VM26 chemotherapy in mice bearing krebs II ascitic tumors

1986 • 5 citations